Form 8-K - Current report:
SEC Accession No. 0001437749-17-012802
Filing Date
2017-07-19
Accepted
2017-07-19 07:01:03
Documents
4
Period of Report
2017-07-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20170718_8k.htm 8-K 32497
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 25776
3 EXHIBIT 99.1 ex99-1.htm EX-99.1 13557
4 logo.jpg GRAPHIC 7011
  Complete submission text file 0001437749-17-012802.txt   82790
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 17970602
SIC: 2834 Pharmaceutical Preparations